Bio Techne | TECH - Equity Capital And Reserves

Stock Price
43.30
Daily Change
-1.44 -3.22%
Monthly
-24.51%
Yearly
-11.90%
Q2 Forecast
42.43

Bio Techne reported $2.09B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Agilent USD 6.91B 167M Dec/2025
Becton, Dickinson and Co. USD 24.13B 1.15B Mar/2026
Bio Techne USD 2.09B 74.32M Mar/2026
Bio-Rad Laboratories USD 6.85B 602.3M Mar/2026
Bruker USD 2.46B 35.9M Dec/2025
Charles River Laboratories USD 2.9B 265.94M Mar/2026
Danaher USD 52.95B 415M Mar/2026
Illumina USD 2.68B 47M Mar/2026
IQVIA Holdings USD 6.22B 282M Mar/2026
Merck EUR 28.59B 344M Dec/2025
Mettler Toledo International USD -41.88M 18.25M Mar/2026
OraSure Technologies USD 313.32M 27.5M Mar/2026
Pacific Biosciences Of California USD 2.37M 2.98M Mar/2026
Repligen USD 2.11B 666K Mar/2026
Revvity USD 7.25B 125.54M Dec/2025
Standard Biotools USD 561.12M 136.83M Mar/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Waters USD 2.56B 230.55M Dec/2025